Immunostaining for thyroid transcription factor 1, Napsin A, p40, and cytokeratin 5 aids in differential diagnosis of non-small cell lung carcinoma

被引:12
|
作者
Ikeda, Satoshi [1 ]
Naruse, Keishi [2 ]
Nagata, Chigusa [1 ]
Kuramochi, Masami [3 ]
Onuki, Takuya [3 ]
Inagaki, Masaharu [3 ]
Suzuki, Keiko [1 ]
机构
[1] Tsuchiura Kyodo Gen Hosp, Dept Pathol, Tsuchiura, Ibaraki 3000053, Japan
[2] Natl Hosp Org Natl Kochi Hosp, Dept Pathol, Kochi 7808077, Japan
[3] Tsuchiura Kyodo Gen Hosp, Dept Resp Surg, Tsuchiura, Ibaraki 3000053, Japan
关键词
immunocytochemistry; lung cytopathology; scoring; FACTOR-I; PULMONARY; P63; ADENOCARCINOMA; EXPRESSION; CANCER; BREAST; DELTA-NP63; SPECIMENS; CYTOLOGY;
D O I
10.3892/ol.2015.3045
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study aimed to examine the effectiveness of immunostaining of cytological specimens in discerning squamous from non-squamous cell carcinoma. Various combinations of six antibodies were examined in order to determine the optimal combination for use in differential diagnosis. Immunostaining was performed using tumor imprint smears obtained from 70 lung carcinoma cases. The results were scored based on positive area and intensity. For objective evaluation, scores for thyroid transcription factor 1 (TTF-1), napsin A, and CK CAM5.2 were expressed with positive values, while those for p40, cytokeratin (CK) 5/6 and CK5 were expressed with negative values. Histograms were produced to evaluate which combination was the most effective in differentiating squamous cell carcinoma from adenocarcinoma. The sensitivity for these molecules in adenocarcinoma was 88% for TTF-1, 85% for napsin A, and 100% for CAM5.2. In squamous cell carcinomas, sensitivity was determined to be 90% for p40, 86% for CK5, and 76% for CK5/6. The specificity for these molecules was calculated as 100%, 95%, 43%, 98%, 100% and 95%, respectively. Each combination was evaluated for scoring and the values were averaged. The most effective combination for mode and mean was TTF-1, napsin A, p40, and CK5, for which all adenocarcinomas had a score >1, and all squamous cell carcinomas scored <-2. Immunostaining scoring may therefore be useful for the differential diagnosis of these carcinomas when a limited number of tumor cells are present.
引用
收藏
页码:2099 / 2104
页数:6
相关论文
共 50 条
  • [31] A Study of ΔNp63 (p40) Expression in Non-Small Cell Lung Carcinomas
    Nonaka, D.
    LABORATORY INVESTIGATION, 2012, 92 : 485A - 485A
  • [32] Merkel cell carcinoma with cytokeratin 20-negative and thyroid transcription factor-1-positive immunostaining admixed with squamous cell carcinoma
    Koba, Shinichi
    Inoue, Takuya
    Okawa, Takeshi
    Tara, Akiko
    Yada, Naomi
    Misago, Noriyuki
    Narisawa, Yutaka
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2011, 64 (01) : 77 - 79
  • [33] Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung
    Pelosi, G
    Fraggetta, F
    Pasini, F
    Maisonneuve, P
    Sonzogni, A
    Iannucci, A
    Terzi, A
    Bresaola, E
    Valduga, F
    Lupo, C
    Viale, G
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (03) : 363 - 372
  • [34] Comparative histopathological and digital scoring between microfluidic and standard immunohistochemistry for p40 and TTF1 on non-small cell lung carcinoma
    Procopio, M.
    Houmani, M.
    Brajkovic, S.
    Leblond, A.
    Dupouy, D. G.
    Soltermann, A.
    VIRCHOWS ARCHIV, 2020, 477 : S124 - S124
  • [35] ΔNp63 (p40) and Thyroid Transcription Factor-1 Immunoreactivity on Small Biopsies or Cellblocks for Typing Non-small Cell Lung Cancer A Novel Two-Hit, Sparing-Material Approach
    Pelosi, Giuseppe
    Fabbri, Alessandra
    Bianchi, Fabrizio
    Maisonneuve, Patrick
    Rossi, Giulio
    Barbareschi, Mattia
    Graziano, Paolo
    Cavazza, Alberto
    Rekhtman, Natasha
    Pastorino, Ugo
    Scanagatta, Paolo
    Papotti, Mauro
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (02) : 281 - 290
  • [36] Role of thyroid transcription factor-1 and P63 immunocytochemistry in cytologic typing of non-small cell lung carcinomas
    Abu Sinna, Eman
    Ezzat, Noha
    Sherif, Ghada M.
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2013, 25 (04) : 209 - 218
  • [37] Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung.
    Pelosi, G
    Fraggetta, F
    Pasini, F
    Maisonneuve, P
    Sonzogni, A
    Iannucci, A
    Terzi, A
    Viale, G
    MODERN PATHOLOGY, 2001, 14 (01) : 225A - 225A
  • [38] Prognostic role of thyroid transcription factor-1 in stage III non-small cell lung cancer
    Berghmans, T
    Mascaux, C
    Martin, B
    Ninane, V
    Sculier, JP
    LUNG CANCER, 2006, 52 (02) : 219 - 224
  • [39] Non-small Cell Lung Carcinoma with Diffuse Co-expression of TTF-1 and p40: Clinicopathologic and Genomic Features of 13 Tumors
    Savari, Omid
    Febres-Aldana, Christopher
    Chang, Jason
    Ventura, Katia
    Bodd, Francis
    Paik, Paul
    Askin, Frederic
    Travis, William
    Rekhtman, Natasha
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1342 - 1342
  • [40] Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung.
    Pelosi, G
    Fraggetta, F
    Pasini, F
    Maisonneuve, P
    Sonzogni, A
    Iannucci, A
    Terzi, A
    Viale, G
    LABORATORY INVESTIGATION, 2001, 81 (01) : 225A - 225A